Indianapolis, IN, December 13, 2016 (Newswire.com) - “Nurses are increasingly becoming decision makers at the point of care,” said Marla J. Weston, PhD, RN, FAAN, chief executive officer of both the American Nurses Association (ANA) and the American Nurses Foundation (the Foundation), the charitable and philanthropic arm of ANA. “Physicians often look to nurses to help guide decision making. Because nursing is consistently ranked as the most trusted profession, the nurse has a very strong role in helping consumers adhere to therapy. Information may actually be more trusted because it is coming from a registered nurse (RN).”
Dr. Weston met with executives and nursing leaders from VMS BioMarketing on a day-long site visit to VMS headquarters on Dec. 6 to share perspectives. They discussed trends such as the transition to outcomes-based medicine, big data and connected health, health consumerism, digital innovation, and the demand for personalized engagement.
"Physicians often look to nurses to help guide decision making. Because nursing is consistently ranked as the most trusted profession, the nurse has a very strong role in helping consumers adhere to therapy."
Marla J. Weston, PhD, RN, FAAN, Chief Executive Officer, American Nurses Association
“Nurse Educators are important to the Foundation’s mission of transforming the nation’s health through the power of nursing,” said Dr. Weston. Opportunities are continuously increasing for nurses, many of whom are finding alternative career choices outside of the hospital, such as Nurse Educators—a trend that Dr. Weston believes is likely to continue.
“Nurses are incredibly well-positioned to teach patients how to comply with therapeutic regimens and how to change their practices and behavior to be more healthy because—fundamentally in their education—they are taught how to be empathetic to the patient’s perspective. Since RNs understand what the world looks like from the patient’s point-of-view, they can help patients navigate making changes, both large and small, to improve their health,” said Dr. Weston.
VMS BioMarketing has developed a strategic partnership with the Foundation as a member of the Foundation’s Corporate Advisory Board, which provides VMS BioMarketing a unique opportunity to discuss developments in nursing and share their perspectives on key issues. Additionally, the board helps identify trends, initiate policy discussions, and lay the foundation for future collaboration that will benefit patients, nurses, and the nation’s health care system.
“Working with the Foundation enables VMS BioMarketing to identify and remain ahead of the relevant trends of tomorrow,” said Abigail Mallon, VMS senior vice president of innovation and strategy. “As VMS continues to innovate on new product offerings and opportunities for nurses, such as nurse navigation services, online health coaching and clinical trial support, our partnership with Dr. Weston and the Foundation provides insight into the always-changing healthcare landscape.”
About VMS BioMarketing
VMS BioMarketing is a leading provider of patient support solutions focused on empowering healthcare providers and patients through education, training, and ongoing health coaching. For more than 20 years, VMS has been dedicated to enabling Nurse Educators to provide the personalized support necessary to help patients successfully start and stay on therapy. VMS clients include the world’s leading pharmaceutical and biotechnology companies. To learn more, please visit www.vmsbiomarketing.com.
About the American Nurses Foundation
The American Nurses Foundation is the charitable and philanthropic arm of the American Nurses Association (ANA), the only full-service professional organization representing the interests of the nation’s 3.6 million registered nurses through its constituent and state nurses associations and its organizational affiliates. The Foundation supports programs that transform the nation’s health through the power of nursing.
Contact Information
Mary J. Minix
(317) 805-6600 Ext. 167
mary.minix@vmsbiomarketing.com
Source: VMS BioMarketing
Share: